Effect of Extracorporeal Shock Wave on Electrophysiological Changes and Pain in Patients With Lower Cross Syndrome

May 17, 2026 updated by: Ahmed Alshimy
Lower Cross Syndrome happens when there is muscular imbalance between weak and tight muscles. The tight muscles are generally the hip flexors and erector spinae, and weak muscles are the abdominals and gluteal muscles. Shortening occurs in the hip flexors while weakening occurs in the abdominals and gluteal muscles.

Study Overview

Detailed Description

Group I (Study): will consist of 20 patients with lower cross syndrome and will receive extracorporeal shock wave in addition to conventional physical therapy program. For 12 sessions every other day, each session for 1 hour.

Group II (Control): will consist of 20 patients with lower cross syndrome and will receive sham extracorporeal shock wave in addition to conventional physical therapy program only same as group (I). For 12 sessions every other day, each session for 1 hour.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Menoufia
      • Sadat, Menoufia, Egypt
        • Al Ryada University for Science and Technology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Forty-four lower cross syndrome patients from both genders their ages ranged from 30-45 years old.
  2. All patients in present study will be ambulant independently.
  3. All patients will be medically stable.
  4. The body mass index (BMI) will be ranged from 20:25 Kg/m2.

Exclusion Criteria:

  1. Patients with musculoskeletal deformities and disorders.
  2. Patients with psychiatric disorders or seizures.
  3. Patients with visual and auditory impairment or tremors influencing balance.
  4. Patients with other neuromuscular disorders.
  5. Patients with BMI more than 25 kg/m2.
  6. Patients with cognitive impairment.
  7. Patients with lower limb or head and brain surgeries.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Study group (I)
Will consist of 20 patients with lower cross syndrome and will receive extracorporeal shock wave in addition to conventional physical therapy program. For 12 sessions every other day, each session for 1 hour.
Stretching and strengthening of Iliopoas muscle and Stretching and strengthening of Lower back muscles

Participants will receive (2.5 bars, 2000 pulses, 5 Hz, 7 min) rESWT with 1500 shock targeting the taut band of erector spinae, and 500 around the taut band, by using an EME S.r.l. via Degli Abeti 88/161122 Pesaro [serial number:

EM12681015], Italy, shock wave generator.

Experimental: Control group (II)
Will consist of 20 patients with lower cross syndrome and will receive sham extracorporeal shock wave in addition to conventional physical therapy program only same as group (I). For 12 sessions every other day, each session for 1 hour.
Stretching and strengthening of Iliopoas muscle and Stretching and strengthening of Lower back muscles
Sham extracorporeal shock wave will be introduced without real shock wave impulses.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Scale
Time Frame: 4 weeks
Assess pain intensity
4 weeks
Electromyograph
Time Frame: 4 weeks
Assess activity of lower back muscles (Erector Spinae)
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 2, 2025

Primary Completion (Actual)

November 28, 2025

Study Completion (Actual)

November 29, 2025

Study Registration Dates

First Submitted

July 29, 2024

First Submitted That Met QC Criteria

July 29, 2024

First Posted (Actual)

August 1, 2024

Study Record Updates

Last Update Posted (Actual)

May 19, 2026

Last Update Submitted That Met QC Criteria

May 17, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lower Cross Syndrome

Clinical Trials on Conventional physical therapy program

Subscribe